Methods, compounds, and compositions for the treatment of angiotensin-related diseases
US-10301298-B2 · May 28, 2019 · US
US12037324B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12037324-B2 |
| Application number | US-202217861809-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 11, 2022 |
| Priority date | Jun 29, 2016 |
| Publication date | Jul 16, 2024 |
| Grant date | Jul 16, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are biased agonists, or β-Arrestin agonists of the angiotensin II receptor, which may be used as medicaments.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I), or salt thereof: wherein ring A is W is N, or CR 16 W′, at each occurrence, is independently selected from N, O, S and CR 16 where at least one W′ is not CR 16 , and at most only one W′ is selected as O or S; R 1 and R 2 are independently selected from H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 alkoxyalkyl, and C 3 -C 6 cycloalkyl; alternatively, R 1 and R 2 , together with the atom to which they are attached, join together to form a C 3 -C 6 cycloalkyl, or a 4 to 6 membered heterocycle having 1-2 heteroatoms, the cycloalkyl or heterocycle is substituted with 0-4 F and 0-1 OH; R 16 , at each occurrence, is independently selected from H, F, Cl, Br, I, CN, OH, N(R a ) 2 , C 1 -C 3 -alkyl, C 1 -C 3 -haloalkyl, C 1 -C 3 -alkoxy, C 1 -C 4 -hydroxyalkyl, C 1 -C 3 -haloalkoxy, C 3 -C 6 -cycloalkyl, and C 3 -C 6 -halocycloalkyl R a is, at each occurrence, independently selected from H, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -hydroxyalkyl, and C 3 -C 6 -cycloalkyl; or two R a , along with the nitrogen atom to which they are attached, join to form a 5 to 6 membered heterocycle containing 0-2 additional heteroatoms selected from N, O and S; Y is 5-tetrazolyl, SO 3 H, PO 2 H 2 , PO 3 H 2 , COOR, R, at each occurrence, is independently selected from H, C 1 -C 6 alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -hydroxyalkyl, C 3 -C 7 cycloalkyl, C 6 aryl-C 1 -C 6 alkyl heterocycle-C 1 -C 6 alkyl, wherein said heterocycle is a 4-10 membered group having 1-3 heteroatoms selected from N, O, or S, said aryl and heterocycle are each substituted with 0-3 groups chosen from C 1 -C 3 alkyl, halo, OH, or C 1 -C 3 fluoroalkyl; R 8 at each occurrence, is independently selected from H, C 1 -C 6 alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -hydroxyalkyl, C 3 -C 7 cycloalkyl, C 3 -C 7 cycloalkyl-C 1 -C 3 alkyl, C 6-10 aryl, C 6-10 -aryl-C 1 -C 6 -alkyl, heteroaryl, heteroaryl-C 1 -C 6 -alkyl, heterocyclyl, heterocycle-C 1 -C 6 -alkyl, wherein the heteroaryl and heterocycle are each a 4-10 membered group having 1-3 heteroatoms selected from N, O, or S; Z, at each occurrence, is independently selected from a bond, O, S, N(R z ), C(R z ) 2 , C═O, C(═O)N(R z ), N(R z )C(═O), C(R z ) 2 C(R z ) 2 , OC(R z ) 2 , SC(R z ) 2 , N(R z )C(R z ) 2 , C(R z ) 2 O, C(R z ) 2 S, C(R z ) 2 N(R z ); R z is at each occurrence independently selected from H, C 1 -C 4 -alkyl, C 1 -C 4 -hydroxyalkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl or, alternatively, two R z groups either on the same atom or on adjacent atoms can join to form a C 3 -C 6 -cycloalkyl or a 4 to 7 membered heterocycle containing 1-2 heteroatoms selected from N, O and S; G is selected from a 4 to 11 membered heterocycle having 1-4 atoms selected from N, O, and S, a C 3 -C8-cycloalkyl, C 6 -C 10 -aryl or a 5 to 10 membered heteroaryl having 1-4 atoms selected from N, O, and S; wherein the heterocycle, cycloalkyl, aryl and heteroaryl are substituted with 0-3 substituents independently selected from the group consisting of ═O, F, Cl, Br, I, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl, C 1 -C 6 -hydroxyalkyl, OH, OR x , SR x , N(R x ) 2 , CO(R x ), CON(R x ) 2 , CO 2 R x , N(R x )CO 2 (R x ), N(R x )CO(R x ), N(R x )CON(R x ) 2 , S(O) 2 (R x ), S(O) 2 N(R x ) 2 , or N(R x )S(O) 2 (R x ); R x is H, C 1-6 alkyl, C 1-4 haloalkyl, C 1-4 hydroxyalkyl, phenyl, CH 2 -phenyl; ring B is Group C is R 5 is C 1-6 alkyl, C 1-6 haloalkyl C 1-6 alkoxyalkyl, C 3-6 -cycloalkylC 0-4 -alkyl which may be substituted with 1-3 halogens or a C 1-3 -alkoxy group; R 6 is H, F, Cl, Br, CF 3 , CN, N(R z ) 2 , CON(R z ) 2 , C 1-4 alkyl, C 1-4 haloalkyl C 1-4 alkoxyalkyl, C 1-4 hydroxyalkyl, C 3-6 -cycloalkyl, C 3-6 -halocycloalkyl, C 3-6 -alkoxycycloalkyl, or C 3-6 -hydroxycycloalkyl; R 9 is COOR, CON(R z ) 2 ; and r is 0 to 3; provided that the compounds of Formula (I) are not 2. A compound of claim 1 , or salt thereof, wherein R 5 is C 1-6 alkyl or C 3-6 cycloalkyl; R 9 is CO 2 H, CO 2 -C 1-6 -alkyl; and R 6 is hydrogen, or C 1-4 alkyl. 3. A compound of claim 1 , or salt thereof, wherein G is selected from a 5 to 10 membered heterocycle having 1-3 atoms selected from N, O, and S, phenyl or a C 6 -C 10 -heteroaryl having 1-3 atoms selected from N, O, and S; wherein the heterocycle, phenyl and heteroaryl are substituted with 0-3 substituents independently selected from the group consisting of ═O, Cl, Br, I, F, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkylthio, C 1 -C 6 -hydroxyalkyl, OH, OR x , N(R x ) 2 , CO(R x ), CON(R x ) 2 , CO 2 R x , N(R x )CO 2 (R x ), N(R x )CO(R x ), N(R x )CON(R x ) 2 , S(O) 2 (R x ), S(O) 2 N(R x ) 2 , or N(R x )S(O) 2 R x ; R x is H, C 1-6 alkyl, CF 3 , phenyl, CH 2 -phenyl. 4. A compound of claim 1 , or salt thereof, wherein Ring B is any of which are optionally substituted with 0-2 F. 5. A compound of claim 1 , or salt thereof, wherein Ring B is any of which are optionally substituted with 0-2 F, Y is COOH, COOMe, COOEt, 5-tetrazolyl, SO 3 H, 6. A compound of claim 1 , or salt thereof, wherein wherein Y is COOH, 5-tetrazolyl, SO 3 H, R=C 1-6 alkyl, C 6-10 -aryl-C 1 -C 6 -alkyl, or (CH 2
with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical · CPC title
having two double bonds between ring members or between ring members and non-ring members · CPC title
not condensed and containing further heterocyclic rings · CPC title
containing further heterocyclic rings · CPC title
Non-condensed quinolines and containing further heterocyclic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.